BackPLx Pharma Overview

PLx Pharma Long Term Debt

Track PLx Pharma's long-term debt ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer average

Loading

PLx Pharma Long Term Debt History

Loading

PLx Pharma vs. peers: Long Term Debt Comparison

Loading

PLx Pharma Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

PLx Pharma (PLXP) FAQ

PLx Pharma (PLXP) currently reports a long-term debt of $0 as of September 2022. In the prior-year period, the figure was $0. Use the charts on this page to explore PLx Pharma's long-term debt history and peer comparisons.

PLx Pharma's long-term debt changed from $0 to $0 (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

PLx Pharma reported $0 in long-term debt as of September 2022. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for PLx Pharma, and consider following PLXP for alerts when major investors trade the stock.

PLx Pharma is classified in the Healthcare sector. On long-term debt, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PLXP with unrelated industries.